Page 19 - Pagetit
P. 19
NEUROSCIENCE OF PSYCHOACTIVE SUBSTANCE USE AND DEPENDENCE
EMCDDA European Monitoring Centre for Drugs and Drug Addiction
ESPAD European School Survey Project on Alcohol and Other Drugs
EEG electroencephalography
FDA United States Food and Drug Administration
FDG fluorodeoxyglucose
fMRI functional magnetic resonance imaging
GABA γ-aminobutyric acid
GBD Global Burden of Disease
HIV Human Immunodeficiency Virus
ICD-10 Tenth Revision of the International Statistical Classification of
Diseases and Related Health Problems
IDU injecting drug use
LAAM Levo-alpha-acetyl-methadol
LSA d-lysergic acid amine
LSD lysergic acid diethylamide
MAO monoamine oxidase
MAOI monoamine oxidase inhibitor
MDA methylenedioxyamphetamine
MDMA 3,4-methylenedioxymethamphetamine
MET motivational enhancement therapy
MRI magnetic resonance imaging
mRNA messenger ribonucleic acid
nAChR nicotinic acetylcholine receptor
NHSDA National Household Survey on Drug Abuse
NIDA National Institute on Drug Abuse
NMDA N-methyl-D-aspartate
NPY neuropeptide Y
PCP phencyclidine
PET positron emission tomography
PMA paramethoxyamphetamine
QTL quantitative trait loci
SACENDU South African Community Epidemiology Network on Drug Use
SPECT single photon emission computed tomography
SSRI serotonin selective reuptake inhibitors
SUD substance use disorders
xviii
Pagetit 18 19.1.2004, 12:36